ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
3,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
4,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
5,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
5,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
6,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
6,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
6,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
6,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
7,3,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7,4,Cardiolipin antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
7,5,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
7,6,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
7,7,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
8,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
8,2,Antinuclear antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
8,3,Cardiolipin antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
8,4,Complement factor decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
8,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
8,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
9,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
9,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
10,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
10,2,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,Y
11,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
12,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
12,2,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
12,3,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
13,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
13,2,Multiple epiphyseal dysplasia,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
13,3,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
15,1,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
15,2,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
15,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
16,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
17,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
18,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
19,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
19,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
19,4,Intestinal diaphragm disease,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
19,5,Normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
19,6,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
19,7,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
19,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
20,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,2,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
21,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,2,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
22,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
23,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
24,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
25,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
25,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
26,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
26,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
26,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
26,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
26,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,1,Blood electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
27,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
28,2,Headache,Headaches NEC,Headaches,Nerv,N
28,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,1,Antiphospholipid syndrome,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
29,2,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
30,1,Skeletal dysplasia,Non-site specific bone disorders congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
31,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
31,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
31,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
32,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
32,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
33,2,Haemangioma,Cardiovascular neoplasms benign,Miscellaneous and site unspecified neoplasms benign,Neopl,N
33,3,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
34,1,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
35,1,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
36,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
36,2,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
36,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
37,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
38,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
39,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
39,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
40,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
40,2,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
40,3,Failed induction of labour,Failed labour,Maternal complications of labour and delivery,Preg,N
40,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
40,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
41,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
41,2,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
41,3,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
41,4,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
41,5,Antiphospholipid antibodies positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
41,6,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
41,7,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
41,8,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
41,9,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
41,10,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
41,11,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
41,12,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
41,13,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
41,14,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
41,15,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
41,16,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
41,17,Salpingectomy,Fallopian tube therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
42,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
42,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
42,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
43,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
43,2,Infantile spitting up,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
44,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
45,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
46,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
46,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
47,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
48,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
49,1,Amino acid level decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
49,2,Blood copper decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
49,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
49,4,Large intestine infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
49,5,Quadriparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
50,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
51,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
52,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
52,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
53,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
54,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
55,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
55,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
55,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
55,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
56,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
57,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
58,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
59,1,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
60,1,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
60,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
61,1,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
61,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,1,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
63,2,Madarosis,Alopecias,Skin appendage conditions,Skin,N
64,1,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
64,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
64,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
65,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
65,3,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
66,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
66,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
66,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
67,2,Product packaging difficult to open,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
67,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
68,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
69,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
69,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
69,4,Copper deficiency,Copper metabolism disorders,Iron and trace metal metabolism disorders,Metab,N
69,5,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
69,6,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
69,7,Quadriparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
70,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
71,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
72,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
72,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
73,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
73,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
73,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
73,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
73,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
74,1,Blood copper decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
74,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
